05:19:53 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-29 Ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 Ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2021-05-19 07:19:02
Circa signs Heads of Agreement for ReSoluteTM plant site



Oslo, 19 May 2021

Circa Group AS (Euronext Growth Oslo: CIRCA) has signed a Heads of Agreement
with Gazel Energie Generation, the owner of the Emile Huchet Site, adjacent to
the Carling Saint-Avold platform and Total Chemesis Composite Park, in
north-eastern France.


The agreement covers the land, buildings, energy, steam and utilities that
enables the parties to complete final costing, environmental assessment and
other evaluations for the site for the ReSoluteTM plant to manufacture up to
1,000 tonnes per annum of the solvent CyreneTM. This agreement has been important
to get in place for the ReSoluteTM project to continue progressing on track and
on schedule.

Circa is the recipient of a EU Horizon 2020 Flagship Grant in part to fund the
design, commissioning and operation of the ReSoluteTM plant with a nominal
production capacity of 1,000 tonnes per annum of CyreneTM. CyreneTM is
manufactured from renewable biomass feedstocks from the platform molecule
Levoglucosenone (LGO).

In February 2021, Circa successfully completed a capital raising of
approximately EUR50 million to finance the construction and operation of the
ReSoluteTM plant.


About Circa
Established in 2006, Circa Group converts waste, non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating novel and
replacement chemicals from renewable feedstocks, Circa is both extracting value
from non-food, waste biomass, and addressing growing market demands for
bio-based alternatives that are driving a more sustainable economy.
www.circa-group.com

Media Contact
Media Contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com
+32 496 116198
www.sustainabilityconsult.com